About the author:
If you have been paying attention to health and wellness conversations over the past year, you have almost certainly encountered the word peptides. Search interest in peptide therapy has grown by over 280% year-over-year, and what was once a niche topic in biohacking circles is now showing up in mainstream medical conversations, social media, and even regulatory headlines. But what are peptides, exactly — and why should the answer matter to someone trying to make informed decisions about their health?
The short version: peptides are not new. Your body already makes them. What is new is how quickly the science — and the marketplace — around therapeutic peptides is evolving. And that speed is precisely why it is important to understand what is evidence-based, what is still emerging, and what questions to ask before considering peptide therapy.
Peptides 101: The Basics
A peptide is a short chain of amino acids — the same building blocks that form proteins. The difference is length. Proteins are long, complex chains of hundreds or thousands of amino acids. Peptides are shorter, typically between 2 and 50 amino acids, which gives them a very different functional profile: they act as signaling molecules, delivering specific instructions to cells and systems throughout the body.
Your body produces peptides naturally and relies on them constantly. Insulin is a peptide. So is oxytocin. So are the GLP-1 hormones that regulate appetite, blood sugar, and metabolic function — the same biological pathway targeted by medications like Ozempic and Mounjaro that have transformed weight loss medicine in recent years.
In therapeutic contexts, synthetic peptides are designed to mimic or amplify these natural signaling pathways. The concept is straightforward: rather than introducing an entirely foreign compound into the body, peptide therapy works with existing biological systems. That principle — working with the body’s own mechanisms rather than overriding them — is one of the reasons peptide therapy aligns naturally with a functional medicine approach.
Why Peptides Are Trending Now
The surge in public interest did not happen in a vacuum. Several converging forces brought peptides into the mainstream almost simultaneously.
The most obvious catalyst is the GLP-1 revolution. Semaglutide and tirzepatide — both peptide-based medications — have become among the most prescribed drugs in the country. Their success in weight management and metabolic health introduced millions of people to the concept that a peptide could be a serious medical intervention, not just a supplement-aisle curiosity. Tirzepatide alone generates roughly 1 million monthly searches in the United States, according to recent research data.
Beyond GLP-1s, the regulatory landscape shifted significantly. In early 2026, a review of the FDA’s peptide classification system opened discussion around reclassifying approximately 14 previously restricted peptides — including compounds like BPC-157 and Thymosin Alpha-1 — back to a category that would allow licensed compounding pharmacies to prepare them under physician prescription. That regulatory conversation, regardless of where it ultimately lands, signaled that peptides are being taken seriously at an institutional level.
And then there is the longevity movement. As research into aging, mitochondrial function, and cellular repair accelerates, peptides have emerged as a natural fit for interventions targeting recovery, immune modulation, and metabolic optimization. Consumer searches for longevity-related peptides grew approximately 300% year-over-year in the past twelve months — a trend driven by both emerging research and a cultural shift toward proactive health management.
The Major Categories of Therapeutic Peptides
Not all peptides serve the same purpose. Understanding the major categories helps clarify what is proven, what is promising, and what remains experimental.
Metabolic and weight management peptides are the most established category. GLP-1 receptor agonists like semaglutide and tirzepatide are FDA-approved, backed by large-scale clinical trials, and represent the gold standard in peptide-based medicine. Next-generation compounds like retatrutide — a triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously — showed approximately 24% mean body weight reduction in Phase 2 trials and entered Phase 3 in 2026. This category accounts for roughly 60% of all peptide-related search traffic and represents the deepest evidence base.
Healing and recovery peptides target tissue repair, inflammation, and gut health. BPC-157, a synthetic fragment of a naturally occurring body protection compound, is the most-searched non-weight-loss peptide at approximately 165,000 monthly searches. TB-500 (Thymosin Beta-4) is studied for muscle repair and flexibility. These peptides are not FDA-approved as finished drugs, though research interest is substantial — BPC-157 alone has generated over 180 PubMed-indexed publications in the past five years.
Growth hormone secretagogues like CJC-1295 and Ipamorelin stimulate the body’s own pituitary gland to release growth hormone in a natural pulsatile pattern, rather than introducing exogenous growth hormone directly. Research suggests potential benefits for sleep quality, body composition, and recovery, though large-scale human trials remain limited.
Immune-modulating peptides such as Thymosin Alpha-1 have been studied for their role in immune regulation, with over 200 publications since 2021 exploring applications in infectious disease and immune support.
Neuropeptides and longevity peptides represent the newest and most rapidly growing category. Compounds like MOTS-c and SS-31 target mitochondrial function — the cellular energy systems that decline with age. GHK-Cu, a copper-binding peptide, has seen over 1,000% year-over-year search growth, primarily driven by interest in wound healing, hair regrowth, and skin repair applications.
How Peptides Are Being Used in Clinical Practice
In a responsible clinical setting, peptide therapy is not about chasing trends or stacking compounds from an online forum. It is about identifying specific biological needs through comprehensive evaluation and determining whether a peptide-based intervention — alone or alongside other treatments — addresses those needs with an acceptable evidence-to-risk ratio.
At Legacy Physicians, I already use the most well-established peptide class in clinical medicine: GLP-1 receptor agonists for medically supervised weight loss. My approach goes beyond prescribing — I monitor for muscle preservation, nutrient deficiencies, and metabolic optimization throughout treatment, because the medication itself is only one piece of the picture.
That same principle — comprehensive evaluation, personalized protocols, and ongoing monitoring — applies to how I evaluate any emerging peptide therapy. The question is never simply “does this peptide do something interesting?” It is: does the evidence support this intervention for this patient, given their specific health picture, and can I monitor outcomes responsibly?
How to Evaluate Whether Peptide Therapy May Be Right for You
Not every peptide is appropriate for every patient, and not every physician offering peptide therapy is approaching it with the same rigor. Here is what to consider:
Start with the evidence. FDA-approved peptide medications like semaglutide and tirzepatide have undergone rigorous clinical trials involving tens of thousands of participants. Compounded peptides, even when legally available, have not gone through that same approval process. That does not mean they lack merit — it means the standard of evidence is different, and your physician should be transparent about where each peptide falls on that spectrum.
Evaluate the physician. Peptide therapy should be prescribed by a physician who conducts a comprehensive evaluation — including lab work, health history, and individualized risk assessment. A physician who will spend 60 to 90 minutes on an initial consultation has the time to do this correctly. One who offers a 10-minute telehealth script does not.
Monitor outcomes. Responsible peptide therapy includes measurable endpoints. What biomarkers are being tracked? What does improvement look like, and over what timeframe? At Legacy Physicians, my membership plans are designed specifically for this kind of ongoing, data-driven care — not one-time prescriptions, but continuous optimization.
Ask about interactions. Peptides do not exist in isolation. They interact with medications, supplements, hormonal status, and underlying conditions. This is particularly important for patients already managing chronic health conditions or undergoing hormone therapy — areas where a functional medicine perspective becomes essential for avoiding blind spots.
Where the Conversation Goes From Here
Peptides are not a fad, and they are not going away. The global peptide therapeutics market is projected to nearly double by 2033, and the clinical pipeline has never been more active — with over 150 peptide-based drugs in active development across metabolic disease, oncology, neurology, and regenerative medicine.
But the speed of commercial interest is outpacing the speed of rigorous evidence in some areas, which means patients need a guide — not a salesperson.
At Legacy Physicians, my approach to peptide therapy is the same approach I take to every intervention: evidence first, personalization always, and ongoing monitoring as a requirement rather than an afterthought. If you are curious about whether peptide therapy belongs in your health strategy, schedule a consultation and we will evaluate it the way it deserves to be evaluated — thoroughly, and with your complete health picture in view.
This is the first post in our peptide series. In upcoming posts, we will take a deeper look at specific peptide categories, how they interact with medications you may already be taking, and what the latest research means for patients making real decisions about their care. To stay informed, contact us or explore our stress management and weight loss services to see how peptide-based interventions fit within a comprehensive care model.
Dr. Corinne Rao is a board-certified internal medicine physician and founder of Legacy Physicians, specializing in functional medicine approaches to weight loss, hormonal health, stress and chronic disease management. Learn about our membership plans and Schedule a consultation with Dr. Corinne at Legacy Physicians.
